Photo Credit: UTSW
Research
Donate
Treatment for Metastatic Kidney Cancer Edges Toward Approval
AVEO Oncology announced today that the Phase 3 TIVO-3 Trial of Tivozanib in metastatic kidney cancer has met its primary endpoint.
Gene Therapy – An RCC Clinical Trial at the NIH
KCCure highlights new and exciting research in kidney cancer at the NIH as well as an RCC clinical trial that is open now for kidney cancer patients.
ESMO18 – Kidney Cancer Updates
KCCure reports live from #ESMO18 on kidney cancer updates and what we learned from the experts.
